FDA Drug recall D-0584-2024
Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare L…
- FDA Drug
- Class II
- terminated
- Published 2024-07-10
On 2024-07-10 the FDA classified a Class II recall of Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare L… by The Harvard Drug Group, citing failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0584-2024 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-06-18 |
| Published | 2024-07-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | The Harvard Drug Group |
| Distribution | US |
Product
Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Major Pharmaceutical 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, USA, NDC 0904-7075-61, UPC code: 309047075614
Reason
Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Identifiers
| upc | 309047075614 |
|---|---|
| code_info | Lot code: M04614, Exp 09/30/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0584-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.